What are the recommended methods for Deep Vein Thrombosis (DVT) prophylaxis?

DVT Prophylaxis: Evidence-Based Recommendations

Primary Recommendation

For hospitalized medical patients at increased risk of thrombosis, use pharmacologic prophylaxis with low-molecular-weight heparin (LMWH), low-dose unfractionated heparin (LDUH), or fondaparinux as first-line therapy. 1, 2, 3

---

Risk Stratification Framework

High-Risk Medical Patients Requiring Prophylaxis

• Acutely ill hospitalized patients with reduced mobility PLUS any of: 1, 3
  • Active malignancy
  • Prior VTE history
  • Age ≥60 years with additional risk factors
  • Acute infection/sepsis
  • Congestive heart failure
  • Severe respiratory disease
  • Obesity (BMI >30 kg/m²)
  • Inflammatory bowel disease

Low-Risk Patients (No Prophylaxis Needed)

• Do NOT use pharmacologic or mechanical prophylaxis in acutely ill hospitalized medical patients at low risk of thrombosis 1

---

Pharmacologic Prophylaxis: Specific Regimens

First-Line Options (Choose One)

1. LMWH (Enoxaparin): 40 mg subcutaneously once daily 1, 2, 3
2. LDUH: 5,000 units subcutaneously three times daily 1, 3
3. Fondaparinux: 2.5 mg subcutaneously once daily 1, 3

Selection Criteria

• Choose based on: dosing convenience (once vs. three times daily), renal function, and institutional cost—clinical efficacy is equivalent 3
• For renal impairment (CrCl <30 mL/min): reduce enoxaparin to 30 mg once daily 2

---

Contraindications to Pharmacologic Prophylaxis

Active Bleeding or High Bleeding Risk

• Do NOT use anticoagulant prophylaxis in patients actively bleeding or at high risk for major bleeding 1
• Instead, use mechanical prophylaxis: intermittent pneumatic compression (IPC) devices OR graduated compression stockings (GCS) 1
• When bleeding risk decreases: substitute pharmacologic for mechanical prophylaxis 1

---

Mechanical Prophylaxis

Indications

• Primary use: patients with contraindications to pharmacologic prophylaxis 1, 2
• Adjunctive use: very high-risk patients (combine with pharmacologic methods) 1

Specific Methods

• Intermittent pneumatic compression (IPC) devices: preferred mechanical method 1
• Graduated compression stockings (GCS): 15-30 mm Hg pressure at ankle 1
• Do NOT use GCS as standalone prophylaxis—insufficient efficacy and risk of skin damage 3

Critical Caveat

• Mechanical prophylaxis alone is INFERIOR to pharmacologic prophylaxis and should only be used when anticoagulation is contraindicated 1, 4

---

Duration of Prophylaxis

Standard Duration

• Continue throughout hospitalization until patient is fully mobile or discharged (typically 6-21 days) 1, 3
• Do NOT extend prophylaxis beyond period of immobilization or acute hospital stay in medical patients 1

Extended Duration (Surgical Patients Only)

• Up to 4 weeks (28-35 days) for: 1, 3
  • Major abdominal or pelvic cancer surgery
  • Hip fracture surgery
  • Patients with residual malignant disease, obesity, or prior VTE history

---

Special Populations

Cancer Patients

Surgical Setting

• All patients undergoing major cancer surgery (laparotomy, laparoscopy, thoracotomy >30 minutes): use LMWH or LDUH 1
• Add mechanical methods in highest-risk patients 1
• Extend prophylaxis to 4 weeks in high-risk features (residual disease, obesity, prior VTE) 1

Ambulatory Setting

• Do NOT routinely use prophylaxis in ambulatory cancer patients receiving chemotherapy 1
• Exception: patients with multiple myeloma receiving thalidomide/lenalidomide-based regimens with steroids 1, 3
• Consider prophylaxis in outpatients with solid tumors PLUS additional risk factors (prior VTE, immobilization, hormonal therapy) AND low bleeding risk: use prophylactic-dose LMWH or LDUH 1

Central Venous Catheters

• Do NOT use routine prophylaxis in cancer patients with indwelling central venous catheters 1

Critically Ill Patients

• Use LMWH or LDUH over no prophylaxis 1
• If bleeding or high bleeding risk: use mechanical prophylaxis (GCS or IPC) until bleeding risk decreases, then switch to pharmacologic 1
• Do NOT perform routine ultrasound screening for DVT 1

Long-Distance Travelers

• High-risk travelers (prior VTE, recent surgery/trauma, active malignancy, pregnancy, estrogen use, advanced age, severe obesity, thrombophilic disorder): 1
  • Frequent ambulation and calf muscle exercise
  • Below-knee GCS providing 15-30 mm Hg pressure at ankle
• All other travelers: do NOT use GCS 1

Chronically Immobilized Persons

• Do NOT use routine thromboprophylaxis in chronically immobilized persons at home or nursing homes 1

---

Common Pitfalls to Avoid

1. Never use mechanical prophylaxis alone when pharmacologic prophylaxis is feasible—it is less effective 1, 3
2. Do not combine mechanical and pharmacologic prophylaxis routinely—use pharmacologic alone unless patient is very high-risk 1
3. Avoid graduated compression stockings as standalone prophylaxis—associated with skin complications and insufficient efficacy 3
4. Do not extend prophylaxis beyond hospital discharge in medical patients—no proven benefit and increases bleeding risk 1
5. Ensure proper fitting and continuous application of mechanical devices—improper use negates benefit 1

---

Algorithm for Decision-Making

Step 1: Assess VTE risk (high-risk = acutely ill + reduced mobility + ≥1 risk factor) 3

Step 2: Assess bleeding risk (active bleeding or high bleeding risk?) 1

Step 3: Select prophylaxis:

• High VTE risk + NO bleeding risk: LMWH 40 mg SC daily OR LDUH 5,000 units SC TID OR fondaparinux 2.5 mg SC daily 1, 3
• High VTE risk + bleeding risk: IPC devices (preferred) OR GCS until bleeding risk resolves, then switch to pharmacologic 1
• Low VTE risk: NO prophylaxis 1

Step 4: Continue until fully mobile or hospital discharge 1, 3